Thomas Gunderson
Thomas Gunderson
bid increasing leaning taking toward
I'm leaning toward J&J not increasing their bid and essentially taking a walk, but it's close.
generally immediate influence
In my experience, these investigations can take years and generally don't have any immediate influence on the fundamentals of the companies.
boston impressive peak scientific team
Boston Scientific has always been impressive -- they've done so many acquisitions over the years. They have a SWAT team that is just at its peak -- they come in and say hey, we're going to do a deal, and boom.
jude price rich stock
St. Jude has a very rich stock price right now.
bid expensive jude pay price
The price that I think you'd have to pay for St. Jude would be even more expensive than what Guidant is being bid for today.